- Home
- SPFI vs HQL Comparison
SPFI vs HQL Comparison
Compare SPFI & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SPFI | HQL |
|---|---|---|
| Founded | 1941 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 843.2M | 689.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPFI | HQL |
|---|---|---|
| Price | $44.11 | $19.49 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $46.00 | N/A |
| AVG Volume (30 Days) | 93.0K | ★ 125.8K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | 1.68% | ★ 11.56% |
| EPS Growth | ★ 17.81 | N/A |
| EPS | ★ 1.82 | 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $22.65 | N/A |
| Revenue Next Year | $9.40 | N/A |
| P/E Ratio | ★ $24.10 | $24.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.34 | $14.06 |
| 52 Week High | $46.94 | $22.67 |
Technical Indicators
Market Signals| Indicator | SPFI | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 36.82 |
| Support Level | $44.05 | $16.83 |
| Resistance Level | $45.56 | $21.32 |
| Average True Range (ATR) | 0.82 | 0.45 |
| MACD | -0.09 | -0.17 |
| Stochastic Oscillator | 36.66 | 12.33 |
Price Performance
Historical ComparisonAbout SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.